Stock News Recap: MacroGenics Inc (NASDAQ: MGNX)
On Friday, MacroGenics Inc (NASDAQ: MGNX) stock dipped -3.22% and closed at 8.71. Its recent trading capacity is 805390 shares versus to its average trading volume of 516374 shares. The company stock lowest price point for the session stood at $8.65. MGNX traded as low as $ 8.65 in the past 52 weeks, and shares hit its peak level to $32.32.
MacroGenics, Inc. (MGNX) recently reported that the first patient has been dosed in the Phase 2/3 MAHOGANY clinical trial of margetuximab, an investigational, Fc-optimized monoclonal antibody targeting HER2, in combination with a checkpoint inhibitor, with or without chemotherapy, as a potential first-line treatment for patients with HER2-positive gastric cancer (GC) or gastroesophageal junction (GEJ) cancer.
“The MAHOGANY study for patients with gastric or gastroesophageal junction cancer is designed to support registration of margetuximab and is a part of our strategy to advance margetuximab in HER2-positive cancers,” stated Scott Koenig, M.D., Ph.D., President and CEO of MacroGenics. “The combination of margetuximab and a checkpoint inhibitor could potentially provide a chemotherapy-free option as a first-line treatment for patients whose tumors are positive for both HER2 and PD-L1 or be used with chemotherapy in a broader HER2-positive population to improve the clinical activity of existing standard of care.”
In the trailing 12 months period, return on assets ratio of the Company was -41.90% and return on equity ratio was -54.50% while its return on investment ratio was -70.50%. The stock price switched down -23.45% 20-Days Simple Moving Average, dropped -32.41% from 50-Days Simple Moving Average and fell -45.22% from 200 Days Simple Moving Average.
Vivian Moore – Health and Biotech
I am Vivian Moore, I have done my bachelor’s in English literature, and further on I did my master’s in Medicines. My most preferred genre of writing is health and biotech. I have been writing from the past 6 years about articles, web content, and blogs. In my career and education, I like to play along with work. I have also been a teacher in the past for 2 years. I use to teach business and technical writing in a very famous university. However, most recently I am working as an instructor, designer, and training writer. I enjoy socializing a lot. I am a very big extrovert when it comes to nature. A part of all this I enjoy exploring the world and traveling makes me happy.
